“alnylam-pharmaceuticals” Archives

in
Entry Author Date Location
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
21 Red Flags to Watch for in a Biotech Company 10/21/13 National
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
The Best Biotech Graduate Schools in Real Life 09/23/13 National
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Dicerna Snags $60M as RNAi Heats Up Again 08/01/13 Boston
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
East Coast Life Sciences Roundup: Verdine, Vedanta, Alnylam, & More 07/05/13 Boston
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Ensysce’s Bet: Combining Two Risky Drug Technologies That Add Up 05/09/13 Texas
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
East Coast Life Sciences Roundup: Aveo, Mayo Clinic, GI Dynamics, More 01/18/13 Boston
Alnylam, Lawsuit Settled, Announces $125 Million Stock Offering 01/15/13 Boston
Alnylam, Tekmira Look Ahead After RNAi Divorce 11/14/12 Boston
Alnylam to Pay Tekmira $65M to Settle RNAi Delivery Dispute 11/12/12 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Alnylam Gets $22.5M From Genzyme for Asia Rights to Amyloidosis Drug 10/22/12 Boston
San Diego Life Sciences Roundup: Regulus IPO, Fate Funding, & More 08/23/12 San Diego
Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company 08/20/12 San Diego
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
Alnylam, Galenea, Gen9, & More from the Boston Life Sciences Roundup 07/20/12 Boston
Alnylam Stock Climbs on Positive Early Trial for Amyloidosis 07/16/12 Boston
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore 06/15/12 National
What Are the Hottest Targets in Biotech Today? 04/23/12 National
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
Reinventing Biotech: Meet Corey Goodman, Kevin Starr & More April 3 02/23/12 Seattle
Page 3 of 10 « previous page · next page »